(Q42835305)

English

Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes

scientific article published on August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

1 reference

based on heuristic

inferred from title

Jacqueline M Stephens

2

object named as

Jacqueline M Stephens

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

author name string

David J Story

1

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

publication date

1 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

1303-1311

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Insulin signalling and the regulation of glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

STATs and gene regulation

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Stat5 is a physiological substrate of the insulin receptor

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

A cellular reporter assay to monitor insulin receptor kinase activity based on STAT 5-dependent luciferase gene expression

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

SOCS-3 is an insulin-induced negative regulator of insulin signaling

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Activation of SOCS-3 by resistin

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Highly specific and quantitative activation of STATs in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Signaling pathways activated by the growth hormone receptor

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Growth hormone, but not insulin, activates STAT5 proteins in adipocytes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Induction of SOCS-3 is insufficient to confer IRS-1 protein degradation in 3T3-L1 adipocytes.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Lack of Socs2 expression causes the high-growth phenotype in mice

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

SOCS3 is essential in the regulation of fetal liver erythropoiesis

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

The role of autoregulation of the hepatic glucose production in man. Response to a physiologic decrement in plasma glucose

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Localization of amiloride-sensitive sodium channels in A6 cells by atomic force microscopy

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Effect of chronic growth hormone treatment on insulin signal transduction in rat tissues

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

The ubiquitin-proteasome pathway regulates lysosomal degradation of the growth hormone receptor and its ligand

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Growth hormone receptor ubiquitination, endocytosis, and degradation are independent of signal transduction via Janus kinase 2.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Common polymorphisms in SOCS3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twins

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

31 March 2020

Growth hormone-induced alterations in the insulin-signaling system

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.148

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/OBY.2006.148

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42835305&oldid=1972401069"